XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Jul. 30, 2023
Jul. 31, 2022
Cash flows from operating activities:    
Net loss $ (3,342) $ (5,699)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation 1,635 1,770
Non-cash inventory (credits) charges (717) 1,421
Amortization 96 105
Stock-based compensation 322 252
Deferred income taxes (86) (15)
Gain sale of equipment (270) (64)
Non-cash restructuring expenses 237  
Foreign currency exchange gain (372) (161)
Changes in assets and liabilities:    
Accounts receivable 2,112 (2,643)
Inventories 1,792 1,223
Other current assets (526) (955)
Other assets (134) 21
Accounts payable – trade (2,353) 9,338
Deferred revenue (166) 848
Accrued restructuring costs 10  
Accrued expenses and deferred compensation (2,311) (413)
Income taxes (362) 281
Net cash (used in) provided by operating activities (4,435) 5,309
Cash flows from investing activities:    
Capital expenditures (513) (711)
Proceeds from the sale of equipment 294 166
Proceeds from note receivable 60  
Proceeds from the sale of investments (rabbi trust) 780 23
Purchase of investments (rabbi trust) (247) (236)
Net cash provided by (used in) investing activities 374 (758)
Cash flows from financing activities:    
Payments of debt issuance costs   (161)
Net cash used in financing activities   (161)
Effect of exchange rate changes on cash and cash equivalents (91) (66)
(Decrease) increase in cash and cash equivalents (4,152) 4,324
Cash and cash equivalents at beginning of period 20,964 14,550
Cash and cash equivalents at end of period $ 16,812 $ 18,874